SukeshiR.AroraMD

PubMed

• 58 citations
  Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer
  Sukeshi R. Patel, Vincent Hurez, Steffan T. Nawrocki, Martin Goros, Joel E. Michalek
  Oncotarget. 2016-07-25
• 7 citations
  Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients.
  Alberto Puccini, Andreas Seeber, Joanne Xiu, Richard M. Goldberg, Davide Soldato
  NPJ Precision Oncology. 2021-10-27
• 42 citations
  Immunotherapy in colorectal cancer: for the select few or all?
  Sukeshi Patel Arora, Devalingam Mahalingam
  Journal of Gastrointestinal Oncology. 2018-02-01

Journal Articles

• An evaluation of elderly patients (70years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research...  
  Al-Rajabi R, Rowe J, Patel S, Mazo-Canola M, Parra A, Goros M, Michalek J, Kelly K, Weitman S, Karnad A, J Geriatr Oncol
• Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing  
  Al-Rajabi R, Chien PC Jr, Cohen S, Tuen M, Arthos J, Chen PD, Patel S, Hioe CE, J Virol
• Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction  
  Al-Rajabi R, Patel S, Ketchum NS, Jaime NA, Lu TW, Pollock BH, Mahalingam D, J Gastrointest Oncol, 1/1/2015
• Beyond VEGF inhibition: Comparative efficacy analysis of novel VEGF and non-VEGF therapeutic agents in phase I trials for patients with metastatic colorectal cancer  
  Patel S, Ketchum N, Pollock B, Sarantopoulos J, Weitman S, Mahalingam D, Mol Cancer Ther, 1/1/2013
• Oncologic Emergencies  
  Patel S, Core Lectures to Internal Medicine Residents, 1/1/2012
• A comparison of races and leukemia subtypes among patients in different cancer survivorship phases  
  Al-Rajabi R, Pandya DM, Patel S, Ketchum NS, Pollock BH, Padmanabhan S, Clin Lymphoma Myeloma Leuk, 1/1/2011
• Cancer Survivorship Study of Perceptions Among Leukemia Patients In the Acute, Extended, and Permanent Survival Phases  
  Patel S, ASH Annual Meeting, 1/1/2010
• A Case of Erythrocytosis with Three Etiologies  
  Patel S, Research Day at UTHSCSA, ACP 2010, 1/1/2010
• Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease  
  Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK, J Infect Dis, 1/1/2005
• Join now to see all

Abstracts/Posters

• Comparative efficacy of sorafenib dose in patients with advanced hepatocellular carcinoma (HCC) with varying liver dysfunction 2014.
  Patel S, Al-Rajabi R, Ketchum N, Lu T, Pollock B, Michalek J, Mahalingam D, GI ASCO, 1/1/2015
• Comparative efficacy of sorafenib dose in patients with advanced hepatocellular carcinoma (HCC) with varying liver dysfunction
  Patel S, Memorial Research Day UTHSCSA, ASCO, 1/1/2015
• Risks and benefits of phase I liver dysfunction studies: Should patients with severe liver dysfunction be included in these trials?
  Patel S, ASCO 2014, ASCO, Chicago, IL, 1/1/2014
• Beyond VEGF inhibition: Comparative efficacy analysis of novel VEGF and non-VEGF therapeutic agents in phase I trials for patients with metastatic colorectal cancer (m...
  Patel S, Ketchum N, Pollock B, Sarantopoulos J, Weitman S, Mahalingam D, ASCO, 1/1/2013
• Hispanic patients in Phase I cancer clinical trials: The Cancer Therapy and Research Center (CTRC) experience
  Patel S, Fifth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, San Diego, CA, 1/1/2012
• Concurrent chemotherapy plus radiation therapy (CRT) in elderly patients (E): A retrospective analysis.
  Patel S, ASCO, 1/1/2010
• Join now to see all

Lectures

• Modulation of autophagy: A phase II study of vorinostat (VOR) plus hydroxychloroquine (HCQ) vs regorafenib (RGF) in chemo-refractory metastatic colorectal cancer (mCRC). 
  2019 ASCO Annual Meeting - 6/1/2019
• Hematology/Oncology Fellowship 
  UTHSCSA, San Antonio, TX - 1/1/2014
• Hematology/Oncology 
  San Antonio, TX - 1/1/2014
• Colorectal Cancer to GI division 
  UTHSCSA, San Antonio, TX - 1/1/2014
• Beyond VEGF inhibition: Comparative efficacy analysis of novel VEGF and non-VEGF therapeutic agents in phase I trials for patients with metastatic colorectal cancer (m... 
  Houston, TX - 1/1/2013
• Lung Cancer and Colorectal Cancer 
  San Antonio, TX - 1/1/2013
• Evaluation of Elderly Patients (>70 Years Old) Enrolled in Phase I Clinical Trials 
  Chicago, IL - 1/1/2012
• Leukemia 
  UTHSCSA, San Antonio, TX - 1/1/2012
• Join now to see all